Private Equity

Staff Writer

Genesys Capital to earn up to 15x its investment on sale of Naurex

–Toronoto firm has now seen its fifth portfolio realization in roughly a year-and-a-half andmay have its best multiple thanks to Naurex acquisition

2 min read · 31 July 2015

Data spotlight: Top Canadian deals in Q2

Toronto-based Real Matters was the top venture deal of the month in Canada, raising C$60 million

1 min read · 26 July 2015

Index of venture-backed stocks keeps level

The index of publicly traded, VC-backed stocks fell slightly to end June at 955.27

1 min read · 24 July 2015

Dashboard: IPOs spike in June

The pace of fundraising scales back in month, while Fitbit leads list of new VC-backed public offerings

2 min read · 21 July 2015

Blue Sky has big dreams

Australian firm holds first close on late-stage fund that it hopes reaches about $23 million

3 min read · 20 July 2015

Avrio Capital sees windfall in Manitoba Harvest's sale to U.S. private equity firm

Canadian firm, which is raising its third fund, sees nine-fold return from sale on the heels of other recent exits

3 min read · 16 July 2015

Guest column: Surviving the coming venture capital fallout

Startups and venture firms need to prepare for when, not if, the valuation bubble bursts

6 min read · 02 July 2015

Natera IPO provides long-awaited relief for Claremont Creek's debut fund

Claremont invested just under $16 million in the genetic-test maker, and its stake is worth $133 million at the IPO price.

2 min read · 02 July 2015

IPO Profile: Xactly Corp

The San Jose, Calif.-based enterprise software developer raised a $56.3 million IPO

2 min read · 01 July 2015

IPO Profile: Seres Therapeutics Inc

The company, which focuses on debilitating infection of the colon, raised a $133.7 million IPO

1 min read · 01 July 2015

Showing 31 to 40 of 5,637 results